We are live on ! Find out more
SCM

Salem Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
–
AUM
$173M
AUM Growth
-$4.41M
Cap. Flow
-$10.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
42.33%
Holding
68
New
2
Increased
15
Reduced
29
Closed
1

Top Buys

1
BAC icon
Bank of America
BAC
+$2.82M
2
GLW icon
Corning
GLW
+$229K
3
BMY icon
Bristol-Myers Squibb
BMY
+$219K
4
ESRX
Express Scripts Holding Company
ESRX
+$209K
5
VOD icon
Vodafone
VOD
+$199K

Top Sells

1
GSK icon
GSK
GSK
+$4.21M
2
NVS icon
Novartis
NVS
+$3.98M
3
DD
Du Pont De Nemours E I
DD
+$3.22M
4
ABBV icon
AbbVie
ABBV
+$920K
5
CVS icon
CVS Health
CVS
+$418K

Sector Composition

1 Healthcare 21.93%
2 Technology 14.18%
3 Industrials 13.46%
4 Consumer Staples 10.46%
5 Energy 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$602B
$8.83M 5.09%
72,785
-2,375
-3% -$270K
HON icon
2
Honeywell
HON
$71.7B
$7.8M 4.5%
74,650
-801
-1% -$82.3K
WY icon
3
Weyerhaeuser
WY
$17.6B
$7.59M 4.38%
254,982
-2,685
-1% -$82.6K
UL icon
4
Unilever
UL
$135B
$7.5M 4.32%
139,116
-3,756
-3% -$193K
CVS icon
5
CVS Health
CVS
$136B
$7.32M 4.22%
76,430
-4,190
-5% -$418K
GE icon
6
GE Aerospace
GE
$361B
$7.29M 4.2%
48,315
-1,288
-3% -$188K
PFE icon
7
Pfizer
PFE
$143B
$7.2M 4.15%
215,510
-7,853
-4% -$251K
MSFT icon
8
Microsoft
MSFT
$2.98T
$7.17M 4.13%
140,059
+500
+0.4% +$26K
MRK icon
9
Merck
MRK
$315B
$6.77M 3.9%
123,123
-577
-0.5% -$30.7K
IP icon
10
International Paper
IP
$20.1B
$5.97M 3.44%
148,859
+581
+0.4% +$23.1K
CSCO icon
11
Cisco
CSCO
$432B
$5.67M 3.27%
197,725
+2,650
+1% +$74.4K
PG icon
12
Procter & Gamble
PG
$353B
$5.61M 3.23%
66,273
– –
DD icon
13
DuPont de Nemours
DD
$18.1B
$5.57M 3.21%
44,256
-217
-0.5% -$28.5K
INTC icon
14
Intel
INTC
$487B
$5.25M 3.03%
160,029
-600
-0.4% -$18.8K
PCAR icon
15
PACCAR
PCAR
$66.7B
$4.64M 2.67%
134,135
+1,125
+0.8% +$41.4K
VZ icon
16
Verizon
VZ
$183B
$4.31M 2.48%
77,156
+2,312
+3% +$120K
VOD icon
17
Vodafone
VOD
$36B
$4.23M 2.44%
136,868
+6,116
+5% +$199K
GLW icon
18
Corning
GLW
$136B
$3.98M 2.3%
194,525
+11,450
+6% +$229K
BAC icon
19
Bank of America
BAC
$432B
$3.85M 2.22%
290,541
+200,850
+224% +$2.82M
SLB icon
20
SLB Ltd
SLB
$70.4B
$3.74M 2.16%
47,299
+512
+1% +$39.2K
BGG
21
DELISTED
Briggs & Stratton Corp.
BGG
$3.72M 2.14%
175,575
-2,800
-2% -$60.5K
HAL icon
22
Halliburton
HAL
$29.3B
$3.25M 1.88%
71,820
-800
-1% -$32.9K
DD
23
DELISTED
Du Pont De Nemours E I
DD
$3.06M 1.76%
47,230
-48,977
-51% -$3.22M
DVN icon
24
Devon Energy
DVN
$49.6B
$3.04M 1.75%
83,918
+1,600
+2% +$54.3K
WRK
25
DELISTED
WestRock Company
WRK
$2.88M 1.66%
73,959
+1,417
+2% +$53.2K
1
2 3

Similar funds

FFC
Fure Financial Corporation Bloomington, Minnesota $122M AUM 1.51% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
SP
StackLine Partners New York $134M AUM 35.15% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
HGM
Highside Global Management Dallas, Texas $136M AUM 36.73% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return

Salem Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Salem Capital Management held 68 positions worth $173M, down 2.5% from $178M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Salem Capital Management withdrew a net $10.3M in Q2 2016, closing 1 position and reducing 29 holdings. Its most notable exit was Apple, an estimated $226K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Salem Capital Management opened a new position in Bristol-Myers Squibb worth $228K.

  • Salem Capital Management's largest Q2 2016 buy was Bristol-Myers Squibb: 3,100 shares worth $228K.
  • Salem Capital Management added most to Bank of America in Q2 2016, an estimated $2.82M increase.
  • Salem Capital Management's biggest Q2 2016 reduction was GSK, cutting an estimated $4.21M.
  • Salem Capital Management fully exited Apple in Q2 2016, selling an estimated $226K.
  • Salem Capital Management's ten largest holdings make up 42% of its $173M portfolio in Q2 2016.
  • Salem Capital Management opened 2 new positions and closed 1 in Q2 2016.
  • Salem Capital Management's portfolio value fell 2.5% quarter-over-quarter to $173M.

Based on Salem Capital Management's 13F filing for Q2 2016, filed 11 Jul 2016.